1. Home
  2. OCS vs NEOG Comparison

OCS vs NEOG Comparison

Compare OCS & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • NEOG
  • Stock Information
  • Founded
  • OCS 2003
  • NEOG 1981
  • Country
  • OCS Switzerland
  • NEOG United States
  • Employees
  • OCS N/A
  • NEOG N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • OCS Health Care
  • NEOG Health Care
  • Exchange
  • OCS Nasdaq
  • NEOG Nasdaq
  • Market Cap
  • OCS 956.4M
  • NEOG 1.1B
  • IPO Year
  • OCS N/A
  • NEOG 1989
  • Fundamental
  • Price
  • OCS $17.64
  • NEOG $4.65
  • Analyst Decision
  • OCS Strong Buy
  • NEOG Buy
  • Analyst Count
  • OCS 3
  • NEOG 3
  • Target Price
  • OCS $35.33
  • NEOG $7.50
  • AVG Volume (30 Days)
  • OCS 13.6K
  • NEOG 5.4M
  • Earning Date
  • OCS 08-26-2025
  • NEOG 07-29-2025
  • Dividend Yield
  • OCS N/A
  • NEOG N/A
  • EPS Growth
  • OCS N/A
  • NEOG N/A
  • EPS
  • OCS N/A
  • NEOG N/A
  • Revenue
  • OCS $847,333.00
  • NEOG $894,661,000.00
  • Revenue This Year
  • OCS $10.23
  • NEOG N/A
  • Revenue Next Year
  • OCS $912.87
  • NEOG N/A
  • P/E Ratio
  • OCS N/A
  • NEOG N/A
  • Revenue Growth
  • OCS N/A
  • NEOG N/A
  • 52 Week Low
  • OCS $10.79
  • NEOG $3.87
  • 52 Week High
  • OCS $23.08
  • NEOG $18.58
  • Technical
  • Relative Strength Index (RSI)
  • OCS 40.60
  • NEOG 39.95
  • Support Level
  • OCS $17.27
  • NEOG $4.71
  • Resistance Level
  • OCS $18.57
  • NEOG $5.47
  • Average True Range (ATR)
  • OCS 0.53
  • NEOG 0.24
  • MACD
  • OCS 0.01
  • NEOG -0.02
  • Stochastic Oscillator
  • OCS 31.11
  • NEOG 5.75

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Share on Social Networks: